00000nam 2200000zi 4500 9.895273 CaOODSP 20240904161416 m o d f cr cn||||||||| 210113t20242024onca ob f000 0 eng d 9780660371115 CaOODSP eng rda CaOODSP n-cn--- H139-17/2024E-PDF Annex 7 to the Good manufacturing practices guide : selected non-prescription drugs. Annex 7 to the GMP guide : selected non-prescription drugs (GUI-0066) version 4 [Ottawa] : Health Canada = Santé Canada, 2024. ©2024 1 online resource (22 pages) : illustrations text txt rdacontent computer c rdamedia online resource cr rdacarrier Cover title. Issued also in French under title: Annexe 7 aux lignes directrices sur les bonnes pratiques de fabrication : certaines drogues en vente libre. "GUI-0066." "Date issued: 29 September 2023." "Replaces: Annex 7 to the Good manufacturing practices guide for drug products – selected non-prescription drugs." "Pub.: 240163." Includes bibliographical references (page 22). "This guide is for people who work with selected non-prescription drugs as: fabricators, packagers, labellers, testers, distributors, importers. This document is an annex to the Good manufacturing practices guide for drug products (GUI-0001). You must read the 2 documents together to understand all relevant guidelines. These guides will help you understand and comply with Part C, Division 2 of the Food and Drug Regulations (the Regulations), which is about good manufacturing practices (GMP)"--About this document, page 4. Nonprescription drug industry Canada. Canada. Health Canada, issuing body. Annexe 7 aux lignes directrices sur les bonnes pratiques de fabrication : (CaOODSP)9.895274 Annex 7 to the Good manufacturing practices guide for drugs products : (CaOODSP)9.887985 PDF 534 KB https://publications.gc.ca/collections/collection_2024/sc-hc/H139-17-2024-eng.pdf HTML N/A https://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/good-manufacturing-practices/guidance-documents/annex-7-good-manufacturing-practices-guide-selected-non-prescription-drugs-gui-0066-overview.html